- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06920550
A Growth Artificial Intelligence Algorithm for leNgth and Weight Study (GAINS)
May 20, 2026 updated by: Nutricia Research
This is a data collection and machine learning accuracy testing project that aims to a) collect training data to enhance, by machine learning, an artificial intelligence (AI) algorithm for measuring length in infants and young children and b) test the accuracy of the AI algorithm by comparing the AI predicted length with the gold standard measured length.
Images and videos will be collected by care givers and healthcare professionals, together with physical length measurements.
These data will be used to train the AI algorithm and to explore potential improvements.
Other data to be collected is user experience feedback.
Study Overview
Study Type
Observational
Enrollment (Estimated)
250
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Rotterdam, Netherlands
- Franciscus Gasthuis
-
-
-
-
-
Wroclaw, Poland
- Ginemedica
-
-
-
-
-
Cadiz, Spain
- Hospital Universitario Puerta del Mar
-
Jerez de la Frontera, Spain
- Hospital Universitario de Jerez dela Frontera
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Child
Accepts Healthy Volunteers
Yes
Sampling Method
Probability Sample
Study Population
Children aged 0 to 24 months.
Description
Inclusion Criteria:
- Infants/young children aged 0 to 24 months old at enrolment;
- Caregiver(s) have access to the internet and a smartphone or tablet to complete questionnaires, take images and videos, and upload these;
- Written informed consent from one or both caregivers (according to local laws) or legally acceptable representative(s) aged ≥ 18 years at enrolment.
Exclusion Criteria:
- Children unable to undergo length or weight measurements when applying standardized techniques recommended by the WHO (e.g. infants/children with structural abnormalities of the lower limbs or orthopaedic conditions (e.g. club foot, hip dysplasia)).
- Research staff's uncertainty about the caregiver's ability or willingness to complete the study according to the instructions
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
|---|
|
Children 0-24 months
Children aged 0-24 months of age with no structural abnormalities of the lower limbs or orthopedic conditions
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Accuracy length AI
Time Frame: Date of enrolment, at baseline
|
Accuracy of the Length AI vs length gold standard (WHO methodology with length board in cm) assessed using several different parameters: the bias (cm), agreement and reliability measures, mean absolute error (cm), mean absolute percentage error (%), percentiles of the absolute error (cm), and root mean square error (cm).
|
Date of enrolment, at baseline
|
|
Accuracy caregiver length
Time Frame: Date of enrolment, at baseline
|
Accuracy of the caregiver measured length (own preferred methodology in cm) vs gold standard measured length (WHO methodology with length board in cm), assessed by same parameters as mentioned in the first primary outcome measure.
|
Date of enrolment, at baseline
|
|
Accuracy caregiver vs AI length
Time Frame: Date of enrolment, at baseline
|
Accuracy of the caregiver measurements (self preferred methodology in cm) vs Length AI by same parameters as mentioned in the first primary outcome measure.
|
Date of enrolment, at baseline
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Accuracy weight AI
Time Frame: Date of enrolment, at baseline
|
Accuracy of the Weight AI vs weight gold standard (WHO methodology with digital scale and tared weighing in kg) assessed using several different parameters: the bias (kg), agreement and reliability measures, mean absolute error (kg), mean absolute percentage error (%), percentiles of the absolute error (kg), and root mean square error (kg).
|
Date of enrolment, at baseline
|
|
Accuracy caregiver weight
Time Frame: Date of enrolment, at baseline
|
Accuracy of the caregiver measured weight (self preferred methodology in kg) vs weight gold standard (WHO methodology with digital scale and tared weighing in kg), assessed using several different parameters as mentioned in the first secondary outcome measure.
|
Date of enrolment, at baseline
|
|
Ease of use tool
Time Frame: Date of enrolment, at baseline
|
The ease of taking images and videos with the tool "GAINS app" on personal mobile device of the caregiver, assessed via a custom made user experience questionnaire.
|
Date of enrolment, at baseline
|
|
Acceptability tool
Time Frame: Date of enrolment, at baseline
|
The expectation and acceptability of the tool "GAINS app" on a personal mobile device of the caregiver, assessed via a custom made user experience questionnaire.
|
Date of enrolment, at baseline
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
December 20, 2024
Primary Completion (Actual)
February 19, 2026
Study Completion (Estimated)
July 31, 2026
Study Registration Dates
First Submitted
December 11, 2024
First Submitted That Met QC Criteria
April 1, 2025
First Posted (Actual)
April 9, 2025
Study Record Updates
Last Update Posted (Actual)
May 22, 2026
Last Update Submitted That Met QC Criteria
May 20, 2026
Last Verified
May 1, 2026
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 23REX0058267
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
IPD Plan Description
Not applicable due to the nature of the project
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Weight
-
Institute of Mental Health, SingaporeCompletedAntipsychotics Weight GainSingapore
-
Pennington Biomedical Research CenterUniversity of California, Los Angeles; United States Department of Agriculture...CompletedPostpartum Weight RetentionUnited States
-
Xinhua Hospital, Shanghai Jiao Tong University...Not yet recruiting
-
Andalas UniversityNational Institute of Health Research and Development, Ministry of Health...CompletedBirth Weight | Pregnancy Weight GainIndonesia
-
University Hospital Center of MartiniqueRecruiting
-
University of TennesseeNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); 59th... and other collaboratorsCompletedWeight Loss | Weight GainUnited States
-
University of RochesterCornell UniversityCompleted
-
University of the PhilippinesPfizerCompletedLow Birth Weight Among NeonatesPhilippines
-
Tehran University of Medical SciencesCompletedWeight Reduction
-
California Polytechnic State University-San Luis...Women Infants and Children program WICCompleted